ProMIS Neurosciences Inc. (PMN NASDAQ) stock market data APIs
$15.0089
-0.44(-2.9%)
as of February 12, 2026
Try our APIs with
free plan!
ProMIS Neurosciences Inc. Financial Data Overview
Price chart is built with
Anychart
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's Disease; PMN267 for treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
Prev. Close
15.0089
Open
14.5671
High
15.0262
Low
14.3738
52 wk Range
6.27-39.75
Market Cap
32 201 K
Shares Outstanding
2 152 K
Revenue
7 558
EPS
-0.24
Beta
-0.093
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ProMIS Neurosciences Inc. data using free add-ons & libraries
Get ProMIS Neurosciences Inc. Fundamental Data
ProMIS Neurosciences Inc. Fundamental data includes:
- Net Revenue: 7 558
- EBITDA: -13 306 319
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.24
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ProMIS Neurosciences Inc. News
New
Five US Stocks See Over $185M in Insider Buying, with Soho House and WR Berkley Leading the Pack
Quick Read Soho House (SHCO) saw a $100M insider purchase as it completed its merger with MCR Hospitality Fund IV. W.R. Berkley attracted $57M in sustained insider buying despite quarterly earnings d...
Exacompta Clairefontaine And 2 Other Leading European Dividend Stocks
As the European market shows resilience with the pan-European STOXX Europe 600 Index rising by 0.77%, investors are keenly observing economic data and earnings results that continue to shape market se...
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers
(RTTNews) - Several small-cap biotech and healthcare names posted notable gains in Thursday's after-hours trading session, with investors reacting to recent corporate updates and clinical milestones. ...
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s disease Clear and near-term value inflection points, with blinded 6-mon...
Get ProMIS Neurosciences Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
